Autopsy report · NCT04341740

Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma

“Study funding was withdrawn.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 9 months before it stopped.
• 6 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Oklahoma

Sponsor type

University, hospital or other

Conditions

Renal Cell Carcinoma; Urothelial Carcinoma

Interventions

Bone Marrow Aspirate

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
  “Funding for study was withdrawn” (97% match in meaning)
• The Influence of Probiotics on Body Weight and Composition
  “study withdrawn due to funding” (92% match in meaning)
• Characteristic Analysis and Surgical Exploration for Acetabular Roof Fractures: Multicenter Retrospective Cohort Study
  “Due to limited funding, the study is now being withdrawn.” (89% match in meaning)
• Pasireotide in Hyperinsulinemic Hypoglycemia
  “Funding was withdrawn by Sponsor prior to start of study” (88% match in meaning)
• Effectiveness and Mechanisms of Recovery Oriented Cognitive Therapy
  “The funds used to originally support the study were withdrawn.” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.